Wegovy and Zepbound Redefine American Health Care Access
A recent surge in the availability of two new weight-loss medications, Wegovy and Zepbound, is prompting significant shifts in how Americans approach health care for obesity. With increased access and shifting guidelines from health organizations, these treatments promise to reshape the landscape of weight management in the United States. What happened Over the past few…